Carolyn E. Taylor insider trades
Open-market stock purchases and sales by Carolyn E. Taylor, Director at Tonix Pharmaceuticals Holding Corp, from SEC Form 4 filings since Jul 16, 2021.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -28%.
Companies traded
- TNXP Tonix Pharmaceuticals Holding Corp: 2 buys, last Jun 12, 2026